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Comparative effectiveness of pharmacological and non-pharmacological interventions 
for orthodontic pain relief at peak pain intensity level – A Bayesian network meta-
analysis   
 
Abstract  
Introduction: Objective of this network meta-analysis (NMA) was to synthesize the evidence 
of comparative effectiveness for various interventions used for orthodontic pain relief during 
peak pain intensity level.  
Methods: The MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials 
databases were searched till 31st December 2014 to identify the relevant studies. Additional 
studies were identified by hand searching of journals and reference lists. Unpublished literature 
was also searched. Eligible studies were randomised-controlled trials (RCTs) evaluating the 
effectiveness of pharmacological or non-pharmacological interventions for pain relief after 
placement of separator or initial aligning arch wire. A covariate adjusted arm-based three level 
hierarchical Bayesian random effects model was used for this NMA.  
Results: 24 RCTs (2,273 participants; male/ females 997/1276; mean age 18.2 years, SD 4.4) 
were included in this NMA. Total 26 interventions were identified which were classified into 
6 classes based on their mechanism of actions. Compared to placebo, ‘NSAIDs’ analgesics and 
lasers were most effective intervention classes with shared median rank of 2 (95% CrI 1 to 3); 
followed by ‘other’ analgesics (median rank 3; 95% CrI 1 to 4); behaviours therapy (median 
rank 4; 95% CrI 3 to 6); and miscellaneous (median rank 5; 95% CrI 3 to 6). The most effective 
individual interventions in ‘NSAIDs’ analgesics and lasers classes were etoricoxib (median 
rank 1; 95% CrI 1 to 3) and GaAs super-pulsed lasers (median rank 3; 95% CrI 1 to 13) 
respectively. Assessment of transitivity and consistency assumption revealed no threat to the 
NMA estimates. There was no evidence for significant publication bias. Heterogeneity was 
mild to moderate (τ2 0.044, 95% CrI 0.040 to 0.055). 
Conclusion: Results show that analgesics and lasers are effective in management of 
orthodontic pain at peak pain intensity level. Further research is required to improve the quality 
of evidence, especially for analgesic interventions. 
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Introduction 
The prevalence of pain during fixed orthodontic treatment is high1; and fear of pain is 
a major concern for many prospective orthodontic patients.2 It is well-known fact that 
placement of orthodontic separators3,4 and initial aligning arch wires1,2 induces pain which 
reaches at peak intensity after 24 hours/ day 1 of orthodontic force application.1-3,5 Therefore, 
management of orthodontic pain at peak intensity level is of paramount clinical importance.   
Recently, pairwise meta-analyses (PMAs) were conducted to provide answers related 
to the effectiveness of pharmacological6 and laser7 interventions for orthodontic pain 
management after separators or initial arch wire placement. However, PMAs have an inherent 
limitation in terms of not utilizing all the available evidence if direct comparisons are not 
provided by all studies included in the PMAs.8 Further, many interventions such as Cognitive 
Behavioural Therapy (CBT), structured phone call and text messages etc., which are used in 
the management of orthodontic pain, have never been included in any of the previous PMAs.  
Comparative Effectiveness Research (CER) relies on the accurate assessment of 
treatment effectiveness of all possible intervention for any given condition to provide evidence 
to inform health-care decisions makers.9,10 The network meta-analysis (NMA), also called 
mixed treatment comparisons (MTC), have extended this concept of CER by providing 
estimates for comparative effectiveness of all competing treatments even when no head-head 
comparisons are available.8-10 Synthesizing all the available evidence (direct and indirect) also 
usually improves the precision of estimates. Therefore, it is recommended that even when 
PMAs exist for any given condition, the results obtained from NMA are more precise.8 
The statistical methods for conducting NMA are broadly classified into two groups- 
Bayesian and Frequentist. Recently, Pandis et al11 have introduced the Frequentist models of 
NMA in the orthodontic field. Both Bayesian and Frequentist models can be effective in 
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conducting NMA, however, Bayesian methods offer certain advantages over the Frequentist 
method. For example, compared to Frequentist method, Bayesian methods allow greater 
flexibility in fitting diverse and complex network of interventions; directly estimates the 
uncertainty in heterogeneity and the associated credible intervals based on the prior 
distribution; and ranking each intervention included in the network as best, second best etc. is 
straightforward based on the joint posterior distribution of all relative treatment effects.8,10,12,13 
Further, the most recent development of a three-level hierarchical modelling approach in 
Bayesian NMA allows inclusion of sparse data wherein even a single study for any given 
comparison can be included in the NMA without compromising the precision of estimates.14,15 
This approach allows strength to be borrowed within the classes of interventions and potentially 
reducing the uncertainty around the individual intervention effects, and consequently allowing 
the ability to rank the interventions and classes independently and inform decision-making 
frameworks.14  
This NMA was undertaken with an objective to assess the comparative effectiveness of 
different interventions and interventions classes used for orthodontic relief after orthodontic 
separator or initial arch wire placement by combining direct and indirect evidence in an arm-
based covariate adjusted three-level hierarchical Bayesian network meta-analysis model. A 
motivation to apply a three level hierarchical modelling is the scarcity of data due to a large 
number of interventions of interest and a relatively smaller number of trials which could 
compromise the precision of the effect estimates and the estimation of heterogeneity.  
Methods  
We followed a standard systematic review protocol according to the PRISMA 
(Preferred Reporting Items for Systematic reviews and Meta-Analysis) guidelines and its recent 
adaptation for NMA.16,17 keeping in mind the fact that excluding treatments from network 
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meta-analyses can adversely affect the findings of NMA;18 the eligibility criteria and search 
strategy were designed to ensure that studies included in this NMA would enable us to compare 
all possible interventions used for orthodontic pain management at peak pain intensity level.    
Eligibility criteria (PICOT) 
We considered the population (patients), interventions, comparator, outcomes and type 
of study (PICOT) to define the eligibility criteria for studies to be included in this NMA. 
Eligible studies were prospective randomised-controlled trials (RCTs) evaluating the 
effectiveness of any pharmacological or non-pharmacological interventions for pain relief. The 
quality of evidence derived from the RCTs is considered as ‘gold standard’ in evaluating the 
interventions effects.19 We did not specify a minimum sample size for inclusion and therefore, 
studies of all sample sizes were included. 
To safeguard against violation of transitivity assumption in NMA, we included studies 
with comparable design characteristics and plausible range of covariate distribution.12,20 The 
target population was defined as the children and adults of both sexes (males and females) with 
orthodontic separator or initial arch wire placement as a part of fixed orthodontic treatment 
procedure. We decided to include studies with orthodontic separator or initial arch wire because 
the patterns and magnitude of pain after placement of separator and initial arch is similar.1-3,5,21 
The index for comparative effectiveness (outcome) was the pain intensity at 24 hours/day 1, 
after separator or initial arch wire placement. Control group (no treatment) was considered 
reference group for comparisons of effectiveness of interventions. Considering the diversity of 
interventions included in this NMA, the interventions would be classified based on the 
mechanism of action. Details are provided in the method and results section of manuscript. 
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Search strategy  
The MEDLINE, The Cochrane Central Register of Controlled Trials (CENTRAL, The 
Cochrane Library), and EMBASE databases were searched to identify the randomized 
controlled trials (RCTs). These databases were searched till December 31, 2014 without any 
restriction for starting date of search or publication language.  
In order to eliminate the possibility of excluding any intervention used for orthodontic 
pain relief and its impact on the NMA findings,18 we did not use interventions as search item, 
rather we searched all studies which had a keyword pain or discomfort in the title and/or 
abstract. All such retrieved studies were then searched to find whether these studies used any 
intervention for orthodontic pain relief.  
Additional studies were identified by hand searching of four major orthodontic journals 
(1980 to December, 2014): American Journal of Orthodontics and Dentofacial Orthopaedics, 
The Angle Orthodontist, the European Journal of Orthodontics and the Journal of Orthodontics. 
Reference lists of the included studies and previously published systematic reviews/meta-
analysis related to the topic were screened for identification of any additional study. 
Unpublished literature was searched by electronically searching Pro-Quest 
Dissertations & Theses database, ClinicalTrials.gov, and National Research Register using 
“orthodontic” and “pain” as search term. Conference proceedings and abstracts were also 
accessed, where possible.  
Study selection and data extraction  
The titles and abstracts of all studies identified by the search strategies were 
independently screened by the first author for removal of duplicate entries and studies which 
failed to meet the objectives of this NMA. Full-text articles of reaming studies were assessed 
independently by two other authors for eligibility based on the predefined eligibility criteria. 
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When disagreement occurred, the article was re-read and discussed until a consensus was 
obtained amongst the authors. A record of all decisions made about the identified studies was 
kept. The review authors were not blinded to author(s), institution or site of publication of 
studies.  
Study characteristics data was extracted using a pilot tested data extraction form. The 
data extracted was: 1) study identification: first author’s name and year of publication 2) study 
design 3) population (participants): sample size, mean age, number of  male and female 
participants, and female proportion 4) interventions: details of pharmacological/non-
pharmacological interventions including the dose; frequency; mode and timing of 
administration  5) comparator and 6) outcome assessment. 
Data was also extracted for potential confounder/s and effect modifier/s which would 
be included in the NMA. Based on the recent evidence available, we identified three effect 
modifiers (age, sex, and baseline pain) which could have affected the estimates, and therefore 
included as priori covariates in our NMA.22,23 Further, we also decided to include another 
potential confounder, orthodontic procedure (separator vs initial arch wire) as covariate to 
adjust for the possible effect of orthodontic procedure on NMA estimates. Hereafter, all four 
would be referred as ‘covariate/s’.  
Primary outcome assessment 
The predefined primary outcome of interest was the patient reported pain intensity at 
24 h/ day 1 after orthodontic procedure. For statistical analysis, we required a mean pain score 
and a level of precision (standard deviation, standard error or 95% confidence interval) 
estimate. If a trial did not report these summary measures, we contacted trial authors for these 
data. Where data was reported only graphically, we contacted the corresponding author for 
numerical data. If this was unsuccessful, the corresponding numerical data was extracted by 
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using the Windows- based digitizing computer program UnGraph (Biosoft, version 5.0, 2004). 
The data extraction by using UnGraph has good reliability and validity.24  
We included trials which assessed pain intensity by using 100 mm Visual Analogue 
Scale (VAS), 10 cm VAS scale or 10 points Numeric Rating Scale (NRS). To standardise to a 
single scale, we assumed that NRS (0-10) and VAS (0-10 cm) were equivalent and these scales 
were converted to VAS (0-100mm) by multiplying pain scores by ten. This method of 
combining 100 mm VAS, 10 cm VAS and 10 points NRS has been used in the recent meta-
analysis.25  If a trial reported multiple effect sizes (e.g. at rest, during fitting teeth together etc.), 
we combined these effect size to get a single estimate, as recommended.26 
Assessment of quality of included trials 
Risk of bias was assessed independently by two authors and all disagreements were 
resolved by discussion. The Cochrane Collaboration risk of bias tool26 was used to assess the 
risk of bias based on the following domains: random sequence generation, allocation 
concealment, blinding of participants and personnel, blinding of assessors, incomplete outcome 
data, selective reporting of outcomes and ‘others’ sources of bias. The ‘others’ source of bias 
was based on the assessment whether male and female participants were similar with respect 
to the mean age. This ‘others’ sources of bias was in relation to assess the clinical heterogeneity. 
Grading the quality of evidence 
The Grading of Recommendations Assessment, Development and Evaluation 
(GRADE) approach recently extended to the NMA was used to grade the quality of evidence.27 
Quality of evidence was synthesized for the comparative effectiveness of each intervention as 
compared to the reference group i.e. control. Although GRADE can be, rather should be 
applied for all comparisons, however depending on the objective of the NMA, it can be applied 
only for the  comparisons of interventions as compared to reference group such as control group 
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in our NMA.16 The domains considered for evaluating the quality of evidence were study 
limitations (risk of bias); intransitivity; inconsistency/indirectness; statistical heterogeneity; 
imprecision (wide credible intervals) and publication bias.27   
Statistical analysis 
A conventional pairwise meta-analysis (PMA) was undertaken to compare the 
interventions if two or more studies included the same pair of interventions as head-head 
comparison. A random effects model (DerSimonian and Laird method) was applied using the 
R ‘meta’ (version 4.3-0) package.28 The statistical heterogeneity was assessed by the Cochran’s 
Q test and the I2 statistic.26 The I2 values of 25%, 50%, and 75% correspond to low, moderate, 
and high level of heterogeneity.26 If more than 10 studies contribute to same pairwise 
comparison, a funnel plot would be drawn to assess the publication bias.26 
For NMA, a recently developed arm based three-level hierarchical Bayesian random 
effects model with ordering constraints14 was used which fully accounts for the correlation 
between comparisons within multi-arm trials.20 Four priori covariates (mean age, proportion of 
females, mean baseline pain and orthodontic procedure) were incorporated into the NMA as 
study level covariates within a network meta-regression framework. The statistical model 
including assumptions employed, inclusion of covariate as part of network meta-regression, 
model run-in/fit evaluation, and the prior distribution and its sensitivity analysis is described 
in detail in the Appendix 1 (online supplementary material).  
NMA was implemented using the WinBUGS software (version 1.4.3), calling it from 
within the R software (version 3.1.2) using the ‘R2WinBUGs’ package.29 Four individual 
chains with disparate starting values were analysed and convergence was assessed using 
Brooks Gelman Rubin (Rhat) statics.
29 The results are based on 100,000 samples, where the ﬁrst 
40,000 samples were discarded from the analyses as a “burn-in.” The graphical presentation 
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for ranking the interventions and intervention classes was done using the Surface Under the 
Cumulative Ranking (SUCRA) values and Rankograms.13 SUCRA allows for ranking the 
intervention based on the overall per cent of surface under the curve. SUCRA would be 1 (or 
100%) when an intervention is certain to be the best (that is always ranks first) and 0 (or 0%) 
when an intervention is certain to be the worst. For presenting the probability that each 
intervention/intervention class is best, 2nd best, 3rd best, etc, Rankogram were used.   
Transitivity and consistency are the important assumptions related to the validity of 
indirect and mixed estimates in NMA.30 The plausibility of transitivity assumption was 
evaluated based on the design characteristics and the methodology of studies included in the 
NMA, as recommended.30 The covariates distribution was assessed at study level as well as for 
the loop specific comparisons and direct comparisons involved in the indirect and mixed 
estimates.  The consistencies between direct and indirect comparisons for all closed loops were 
evaluated using the ‘node-splitting’ method.14,31 ‘Node-splitting’ method is based on the 
calculation of two posterior distributions, one of which is derived from trials that directly 
compare the interventions (e.g. interventions X and Y), dDirxy, whereas the other is indirectly 
derived from the remaining trials dIndxy. To test for consistency between direct and indirect 
estimates i.e. probability that the direct estimate surpasses that of the indirect estimate, a 
Bayesian p value was calculated.14 
The heterogeneity was estimated from the median of the posterior distribution of the 
between trial variance, tau square (τ2). The tau square is a valid parameter to assess and quantify 
the magnitude of heterogeneity in a random effect meta-analysis.26,32 The square root of tau 
square i.e. tau (τ) shows the standard deviation of underlying effects across studies study.7,26  
In the Bayesian hierarchical random effect models, the definition and interpretation of τ2 is 
similar to conventional random effect models.33 Similar to recently published NMA34, we 
defined heterogeneity to be mild if  τ2 <  0.04, moderate if τ2  0.04-0.14, and severe if τ2 > 0.40. 
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Small study effect was assessed using the meta-regression based approach recently 
introduced to Bayesian framework NMAs.20,35 This approach is based on the assumption that 
biases are exchangeable across the network, i.e. biases, if present, operate in a similar way in 
trials across the network.35,36 Therefore, we extracted the pairwise estimates from the NMA in 
a way which would reflect that in trials comparing active and inactive treatments (e.g., placebo, 
control group), it could be reasonably assumed that the active treatment would be favoured by 
small-study bias.35 Similar approach was used to extract pairwise estimates to draw the 
comparison-adjusted funnel plot to assess the small study effects. The comparison-adjusted 
funnel plot was drawn by using the ‘netfunnel’ command37 in Stata software (version 13). 
Considering the fact that interventions in our NMA were beneficial in nature, therefore, funnel 
plot asymmetry with fewer studies lying on the left side of zero would indicate that small-study 
effects favour the active treatments.37 
Results 
Search results and characteristics of studies included in the NMA 
The search strategy details are provided in the Appendix 2 (online supplementary 
material). Total 236 RCTs were identified from the search strategy. After removing duplicates, 
a total of 99 RCTs remained, from which we identified 24 RCTs38-61 relevant for our review. 
The PRISMA flow diagram is shown as Figure 1.  
The characteristics of studies included in the NMA are presented in the Appendix 3 
(online supplementary material) and summarised in Table 1 and Table 2. Total 2,273 
participants (male=997, 43.86%; females=1276, 56.14%) were included with mean age of 
18.22 years (SD=4.40), female proportion of .54 (SD=.05), mean baseline pain VAS score 2.56 
(SD=3.17). 14 RCTs used orthodontic separator as orthodontic procedure whereas remaining 
10 RCTs used initial arch wire as orthodontic procedure. VAS was used for assessment of pain 
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across all studies. Two RCTs were of split-mouth design42,47 and one RCT was of cross-over 
design.52 We followed the recommended procedure26 to extract the relevant data so that these 
three non-parallel design RCTs could also be included in the NMA along with the rest of the 
parallel design RCTs.  
The evidence network plot is shown in Figure 2. Total 26 different interventions were 
identified across all 24 RCTs which were further classified into following six classes based on 
their mechanism of action: These were 1) placebo, 2) ‘NSAIDs’ analgesics, 3) ‘others’ 
analgesics, 4) lasers, 5) behaviours therapy, and 6) miscellaneous. The detail of individual 
intervention and respective intervention classes is provided in Table 1. The rationale and 
justification of interventions classification is provided in the Section C of Appendix 1 (online 
supplementary material).  
Risk of bias assessment 
Risk of bias assessed for each individual study is shown in Figure 3. For two studies, 
risk of bias was high for randomization process.38,55 There was no evidence for high risk of 
bias for any other domain, though few studies did not provide relevant information; and thus 
assigned unclear risk of bias. Considering the fact that many studies used non-pharmacological 
interventions and it could have been impossible for the investigators to design double blind 
trials, therefore a judgement based on the consensus amongst authors was used to assess the 
risk of bias for two domains related to the blinding process.   
Pairwise meta-analysis (PMA) findings 
The results of random effect PMAs for 10 pairwise comparison (for which two or more 
studies studied the same comparison) is presented in the Appendix 4 (online supplementary 
material). The heterogeneity (I2) varied from 0% to 69% and all effect sizes were associated 
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with wide 95% CI. Since number of studies for each comparison were few (maximum 5 studies 
per comparisons), therefore we did plot conventional funnel plot to assess small study effect.  
Network meta-analysis (NMA) findings  
Tables 3 show the summary of NMA results. The covariate adjusted model had 
substantially better fit as compared to the non-adjusted model as shown by the DIC (Deviance 
Information Criterion) value which was smaller by approximately 68 units. The distribution of 
study level covariates included in the NMA as presented in Table 2. The models incorporating 
ordering constraints were of a better ﬁt as compared to the non-constrained models and thus, 
the results presented are based on estimates derived from the constrained NMA. The summary 
of NMA estimates with and without the ordering constraints are presented in Appendix 5 
(online of supplementary material).   
The pair-wise summary forest plot for each intervention is shown in Appendix 6 (online 
supplementary material). Interestingly, the NMA derived direct estimates are more precise as 
compared to the corresponding direct estimates available from the PMAs. This was particularly 
true where heterogeneity was large in the PMAs. For example, the Placebo_Pharmacological 
Vs Naproxen_Premptive_Postoperative with moderate to high heterogeneity (I2 69.1%) had 
wide 95% CI for PMA (estimate -19.62; 95% CI -38.05 to -1.20) as compared to the narrow 
95% CrI in NMA (estimate -17.96; -28.53 to -8.12). This probably is due to the fact that the 
estimates from NMA are adjusted for the covariates.  
Interestingly, the direct estimates within the NMA were more precise than the 
indirect/mixed NMA estimates. A reason for this paradox could be the common heterogeneity 
assumption in the model used for NMA. Under the assumption of common heterogeneity, 
comparisons with little or no heterogeneity share the same heterogeneity with comparisons 
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with large heterogeneity and as a result the NMA estimates appear to be less precise than the 
respective direct estimates.30 
Table 3 summarizes the median rank and SUCRA values for each individual 
intervention and interventions classes. Figures 4 summarizes the pair-wise estimates of 
interventions as compared to the reference i.e. control group. The etoricoxib was the most 
effective intervention as compared to the control (estimate -41.96; 95% CrI -52.85 to -30.69) 
with a median rank of 1; followed by GaAs super-pulsed laser (estimate -34.01; 95% CrI -
42.57 to -25.66) and pre-emptive piroxicam (estimate -33.72; 95% CrI -45.17 to -21.82) with 
a shared median rank of 3. Figure 5 show the SUCRA plot for all interventions. The 
Rankograms for each individual intervention are shown in Appendix 7 (online supplementary 
material). 
Compared to placebo, ‘NSAIDs’ analgesics (estimate -19.67; 95% CrI -28.81 to -10.71) 
and lasers (estimate -19.66; 95% CrI -30.15 to -9.15) were the most effective intervention 
classes with shared median rank of 2; followed by ‘others’ analgesics class (estimate -15.26; 
95% CrI -25.44 to -5.41) with median rank of 3. The behaviours therapy and miscellaneous 
intervention classes were not significantly effective as compared to placebo class (Figure 6). 
Figure 7 show the SUCRA plot for all intervention classes. The Rankograms for each 
intervention classes are shown in Appendix 8 (online supplementary material). 
Sensitivity analysis for priors  
Sensitivity to the prior distribution for the between-study variance and the intervention 
class variances showed little evidence of an impact on the overall effect estimates and 
precision, as shown in Appendix 9 (online supplementary material). This suggests that all sets 
of analyses are insensitive to the choice of the prior distributions and NMA estimates are not 
effected by prior distribution. 
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Transitivity and inconsistency assessment 
The transitivity assessment, based on the recent recommendation,30 revealed no major 
threat to transitivity assumption from study design characteristics. We adjusted the NMA 
estimates by including covariates as part of network meta-regression which further improve 
the plausibility of the transitivity assumption.30 The covariate distribution for loop specific 
comparison as well as direct pairwise comparisons is presented in the Appendix 10 (online 
supplementary material).  
Results from ‘Node split’ method to estimate the inconsistency shows no substantial 
evidence for inconsistency (Table 5). Out of total 41 comparisons which provided both direct 
and indirect estimates and eventually included in the node split method inconsistency 
estimation, three comparison namely, acetaminophen (pre-emptive and postoperative) vs 
etoricoxib (pre-emptive and postoperative); placebo (pharmacological) vs aspirin (pre-emptive 
and postoperative); and placebo (pharmacological) vs etoricoxib (pre-emptive and 
postoperative) which constitutes 7.3% of total evidence examined (3/41=0.0731), showed 
significant inconsistency. Results show that covariate adjustments improved the consistency of 
NMA. For example, the number of comparisons with significant inconsistency (Bayesian p 
value < 0.05) was eight (19.5%) for unadjusted NMA whereas only three comparisons (7.3%) 
were inconsistent when covariates were included in the NMA. Further even for three 
comparisons which showed inconsistency in covariate adjusted NMA, the inconsistency 
estimate was less as compared to the non-adjusted NMA. The results for the ‘Node split’ 
method to estimate the inconsistency without covariate adjustment is shown as Appendix 11 
(online supplementary material). 
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Heterogeneity and publication bias assessment  
The NMA heterogeneity estimated from the median of the posterior distribution of the 
between trial study τ2 was 0.044 (95% CrI 0.040 to 0.055), suggesting a mild to moderate 
heterogeneity.33 The summary of NMA and heterogeneity estimate (τ2) with and without 
adjustment for covariate/s is presented in the Appendix 12 (online supplementary material). 
The heterogeneity explained by covariate/s was calculated as the difference between the 
heterogeneity estimate after the inclusion of covariate/s (τa2) and before the inclusion of 
covariate/s (τb2). Thus, the difference τa2 - τb2 quantifies the amount of heterogeneity explained 
by covariate/s.  A negative sign would indicate that heterogeneity decreased after inclusion of 
covariate/s. The amount of heterogeneity explained by inclusion of age, sex, baseline pain and 
orthodontic procedure was - 0.011 (0.088 - 0.099); - 0.030 (0.069 - 0.099); - 0.028 (0.071 - 
0.099); and - 0.013 (0.086 - 0.099) respectively. The overall heterogeneity explained by 
including all four covariates in the NMA was - 0.055 (0.044 - 0.099). 
The meta-regression model applied to Bayesian NMA estimates suggests an overall 
tendency for a small study effect in the network (mean slope estimate -9.73; 95% CrI −25.31 
to 7.65), however this effect was not significant as the 95% CrI includes zero. This finding is 
substantiated by the comparison adjusted funnel plot (Figure 8) which shows no substantial 
asymmetry. 
Quality of evidence 
Quality of evidence varied from very low-to-high for direct comparisons, and very low 
to moderate for indirect comparisons and NMA estimates (Table 4). The quality of evidence 
for intervention classes can be inferred from the quality of evidence assigned to the constituting 
interventions. For example, the quality of evidence was very low-to-low for placebo class; low 
to moderate for the ‘NSAIDs’ analgesic classes and ‘others’ analgesics; moderate to high for 
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lasers; moderate to high for behaviour therapy; and very low to moderate for miscellaneous 
class. 
Discussion 
In general, our results substantiate the various claims made recently in relation to the 
NMA. Firstly, our findings support the fact that NMA estimates are more precise as compared 
to direct pairwise estimates obtained from the conventional PMAs.8 Secondly, use of three 
level hierarchical structure and incorporating the ordering constraints does provide precise 
estimate even when number of interventions is large and few studies are available for each 
comparison. More importantly, this framework provides the ability for independent ranking of 
closely related interventions.14 For example, in our NMA, the median rank of pre-emptive 
ibuprofen, postoperative ibuprofen and combined pre-emptive postoperative ibuprofen were 
15, 12 and 8 respectively (Figure 4) despite the fact that these three interventions were same 
except for the timing of administration. Thirdly, the covariates adjusted models provide 
unbiased NMA estimates10,20,23; reduces the heterogeneity and inconsistency; and improves 
model fit.10,20,23 
Although categorizing the interventions into their respective classes for the class-based 
NMA increased the precision of the effect estimates, however it restricts the interpretability of 
the result at an individual intervention level.14 Therefore, for the inference purpose, we will be 
placing emphasis on the intervention class effect while discussing the contribution of each 
individual intervention in the respective class. 
Results shows that compared to placebo (least effective intervention class with median 
rank 6), ‘NSAIDs’ analgesics and lasers were the most effective intervention classes, followed 
by the ‘others’ analgesics. The behaviour therapy and miscellaneous classes were not 
significantly better than placebo. 
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Etoricoxib (pre-emptive postoperative) was the most effective intervention in the 
‘NSAIDs’ analgesics class. This finding is in agreement with previous studies which reported 
that etoricoxib is more effective in reducing the acute pain as compared to other commonly 
used NSAIDs.62 Etoricoxib is a second-generation, highly selective cyclooxygenase 2 (COX-
2) inhibitor with anti-inflammatory and analgesic properties.63 It has a dose dependent 
inhibitory effect on COX-2 across the therapeutic dose range, and possesses a long plasma half-
life duration of 22 h.63 The high effectiveness of etoricoxib observed in our NMA could be 
attributed to the fact that there was an accumulative dose of 120 mg (60 mg pre-emptive and 
60 mg post-operative within few hours) administered to participants as evident from the study 
characteristics data (Appendix B), thereby enhancing its effectiveness which is a dose 
dependent phenomenon. 
Our finding suggests that the effectiveness of analgesics depends on the 
pharmacokinetics, and therefore, should be carefully considered during the selection of 
analgesics in terms of dose and timing of administration. For example, analgesics with long 
plasma half-life like pirocixam (18-20 h),63 naproxen (approximately 15 h)63 and lumiracoxib 
(12 h)63 were  effective (median rank within the 10 most effective interventions; and in the 
same order as their plasm half-life) when administered as only pre-emptive analgesic. 
However, the analgesics with shorter plasm half-life like ibuprofen (4-8 h)63 and aspirin 
(approximately 6 h)63 were in the top 10 interventions only when these analgesics were 
administered as combination of pre-emptive and post-operative analgesics. Acetaminophen 
was less effective in reducing pain perhaps because of its central mechanism of action which 
results in greater anti-pyretic effect as compared to its analgesic effect.63 Further, the plasma 
half-life of acetaminophen is also short (2-5 h).63 
Lasers were the second most effective intervention class. Several mechanisms have 
been proposed which could explain the analgesic efficacy of low-level laser therapy (LLLT) 
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for pain relieving such as, the gate theory, modulation of endorphin production, the anti-
inflammatory effect, and the direct inhibition of neural activity.64 Our results show that super 
pulsed gallium-arsenide (GaAs) laser is more effective compared to other lasers. This higher 
effectiveness of super pulsed GaAs laser could be attributed to the fact that the pulsed light is 
represented by pulse on and off periods, which allows LLLT therapy with higher peaks of 
power compared to those allowed in conventional lasers.65 As a result, the super-pulsed lasers 
can achieve greater penetration depth without increasing the tissue temperature.65 Interestingly, 
our findings supports this hypothesis of correlation between wavelength and effectiveness of 
lasers. In our NMA, wavelength used for the super pulsed GaAs laser (910 nm) was greater as 
compared to the AlGaInP laser (635 nm) and AlGaAs laser (670-830 nm); and the effectiveness 
of these lasers was in the order of their wavelength with the median rank of 3, 7 and 11 for 
super pulsed GaAs, AlGaInP and AlGaAs lasers respectively (Figure 4). 
Amongst the behaviour therapy interventions, Cognitive Behavioural Therapy (CBT) 
was more effective compared to structured phone call and text messages. This could be due to 
the differences in the methodology of implementation of these procedure adopted in the studies 
included in our NMA. In both phone call and text message interventions, participants were 
asked about their pain and were reassured about their concerns regarding the pain, however no 
active psychological counselling was offered. However in CBT intervention, an active 
approach was adopted which involved guided relaxation training, assistance in tackling pain-
related anxiety etc. Further, the therapists detailed the pain that might occur and patients were 
assured that pain will decrease gradually.61  
For the miscellaneous intervention class, benzocaine local anaesthetic patch and TENS 
were more effective (shared median rank 20) as compared to vibrational appliance. Lesser 
effectiveness of vibration appliance could be attributed to the fact that vibration from the 
appliance could have negated the pain reliving ability of these appliances by actually causing 
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hurt to the already tender tooth owing to pain caused by orthodontic forces. The only conclusive 
evidence which supports the effectiveness of vibrational appliances in relieving dental pain has 
been provided by study wherein vibrations were applied to the skull and facial region, and not 
directly to the dentition.66 
Our results, adjusted for covariates, suggests that there is no significant placebo effect 
at peak pain level after 24 h of orthodontic force application. This finding is in agreement with 
the recent meta-analysis which investigated placebo response.25 Authors concluded that 
placebo response was significant only at the earliest time period (within 15-30 minutes) and 
there was no significant evidence of placebo response at any of the other time periods.25  
Quality of evidence 
Results revealed a great variation (very low to high) in the quality of evidence across 
comparisons. The factors which lowered the quality of evidence for various comparisons 
included risk of bias in few studies, inconsistency across few comparisons and intransitivity 
owing to the different types of interventions included in the estimation of indirect evidence. 
Lasers, as individual interventions and as intervention class, achieved the satisfactory quality 
for the direct, indirect as well as NMA estimates. This perhaps could be due to the fact that 
studies which investigated the efficacy of lasers in relieving orthodontic pain that were recently 
conducted, and thus were of higher quality.  
Strength and limitation 
The strengths of our NMA include: a) we were able to extract required data for the 
NMA from all 24 suitable trials identified by a comprehensive and inclusive search strategy; 
b) the three level hierarchical Bayesian model selected to perform NMA imparts confidence in 
our results because this model can handle complex network of evidence with sparse data, and 
yet provide precise estimates owing to the borrowing of strength across intervention. Further, 
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this model allowed us to have independent estimate and ranking of each individual intervention 
as well as intervention classes; c) our results are adjusted for all major covariates which could 
have affected the outcome; and d) there was no major threat to findings from any potential 
source of bias such as heterogeneity, inconsistency and publication bias. 
However, there are several limitations. Perhaps the most important limitation pertains 
to the fact that we synthesized evidence only for peak pain intensity level at 24 h, and thus not 
utilized the data available for other time points. Our decision to include only the peak pain 
intensity level time was mainly based on the fact that studies included in this NMA provided 
pain data at varying time points, except for peak pain intensity level. For example, the timing 
for pain assessment varied from 4 h, 6 h, 8 h, 12 h, day 3, day 2, day 5 etc. Another limitation 
pertains to the fact that we combined multiple time point of pain assessment to define the 
baseline pain. Again this decision was based on the fact that there was no uniform timing of 
baseline pain assessment across trials included in this NMA. To minimize the influence of such 
limitation, we selected a window period of first 2 h for baseline pain assessment; and included 
baseline pain as a covariate in the NMA. 
Implications for practice and research 
This is perhaps the first comprehensive meta-analysis undertaken to evaluate the 
effectiveness of various interventions for orthodontic pain relief.  Our findings show that 
selection of pharmacological interventions (analgesics) should be guided by appropriate 
knowledge of their mechanism of action as well as the pharmacokinetics such as plasma half-
life period. Based on this knowledge, a clinician can build his/her own analgesic protocol using 
the multimodal analgesia approach which combines different classes of analgesics and methods 
of pain management to provide superior pain relief than any one class or method alone. The 
basic principle is that using various classes of medications will simultaneously and 
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synergistically inhibit the different pain receptor pathways. The combination reduces the dose 
of each analgesic and thereby decreases the incidence of side effects of any particular 
medication used.63 An important component of multimodal analgesic therapy is the pre-
emptive analgesia followed by adjuncts analgesics inform of post-operative analgesics. Pre-
emptive analgesia is an anticipatory aesthetic approach that intends to prevent the pain and 
inflammatory response initiated by surgical incision and manipulation, and prevent the "wind-
up phenomenon''.63  
We believe that our NMA will help in guiding the future research in area of orthodontic 
pain management. The detailed ranking of individual interventions along with the possible 
source of available evidence (direct, indirect or NMA) would guide the researchers to select 
appropriate comparative interventions while planning the research. This will fill the existing 
gap wherein no direct evidence is available for such comparisons. It will be interesting to see 
how multimodal analgesia could influence the orthodontic pain management. 
Agreements and disagreements with other reviews 
We are not aware of any other review/NMA of comparative effectiveness of 
pharmacological and non-pharmacological interventions for orthodontic pain relief. Our 
findings support the evidence provided by previously conducted PMAs which concluded that 
analgesics6 and lasers7 are effective in relieving orthodontic pain, and pre-emptive use is 
promising especially for long-acting non-steroidal anti-inflammatory drugs (NSAIDs).6 
Conclusion  
The result shows that analgesic and lasers are the effective interventions to manage 
orthodontic pain at peak pain intensity level. Etoricoxib seems to be most effective analgesic 
owing to its dose dependent analgesic effectiveness and long plasma half-life period. Amongst 
lasers, super-pulsed laser is more effective as compared to the continuous pulse lasers owing 
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to its deeper tissue penetration. Further, research is required to improve the quality of evidence 
especially for analgesic interventions. Placebo are least effective in managing orthodontic pain 
at peak pain intensity level.  
 
Figure captions  
Figure 1 PRISMA Flow Diagram 
Figure 2 Evidence network plots showing the pharmacological and non-pharmacological 
intervention included in the network meta-analysis (please refer to Table 1 for more details). 
Thickness of nodes correspond to the total number of studies using this intervention. The edge 
thickness (showing numbers) shows the total number of studies making this comparison. 
Figure 3 Risk of bias summary 
Figure 4 Summary forest plot showing pair-wise estimates of each individual intervention as 
compared to the control group 
Figure 5 Surface Under the Cumulative RAnking curve (SUCRA) for interventions 
Figure 5 Summary forest plot showing all pair-wise estimates for interventions class 
Figure 7 Surface Under the Cumulative RAnking curve (SUCRA) for interventions class 
Figure 8 Comparison adjusted Funnel plot. 
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